Orrick has advised OptAsia Healthcare, a Hong Kong-based healthcare technology firm, on its joint venture with Redwood City, CA-based Soleno Therapeutics (NASDAQ:SLNO) and its subsidiary Capnia…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
